NCT01027234View on ClinicalTrials.gov

This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral Doses

PHASE1TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Healthy
Interventions
DRUG

AZD8418

Single oral dose

DRUG

Placebo

single oral dose

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY